Printer Friendly

Detection of E. coli O157:H7 and Shigella dysenteriae toxins in clinical samples by PCR-ELISA.

Introduction

Shiga toxins belong to a large family of bacterial toxins with two major groups, stx1 and stx2. (1) These virulence factors are mainly produced by Shigella dysenteriae and Shigatoxigenic group of Escherichia coli like E. coli O157:H7 which are able to cause infectious diseases. (2,3) The toxin is one of the [AB.sub.5] toxins and has binding (B) and catalytic domains (A). The pentameric B subunit of the toxin is responsible for receptor binding and intracellular trafficking of the holotoxins. (4) The toxin binds to Gb3 located on cell surfaces and is introduced by endocytic uptake. N-glycosidase activity of the A subunit inhibits protein synthesis in the cell and causes cell death. (5) In some cells these toxins also trigger cytokine synthesis and induce apoptosis, which is caused by ribotoxic stress. (6) The gene encoding toxin in Shigella dysenteriae is chromosomal. However stx gene in E. coli O157:H7 is associated with a prophage. (7) Different subtypes of shiga toxin are identified as stx1, stx1c, stxfc, stx2, stx2e, stx2d and stx2g. (8)

Infections by shiga toxins producing bacteria have worldwide prevalence and are widespread in developing countries such as south-eastern Asian countries, Indian subcontinent, South Africa, central Asia, and Bangladesh. (9) Infection of Shiga toxin producing bacteria is a major health concern even in developed countries all over the world. These bacteria are potential cause of diarrhea, hemorrhagic colitis, severe inflammations of ileocolonic regions of the gastrointestinal tract, thrombocytopenia, septicemia, central nervous system (CNS) involvement, malignant disorders in urinary ducts, and hemolytic uremic syndrome (HUS). (10) urinary tract infection by EHEC is mainly generated by E. coli O157. In children under five years old and adults over 60, as they have the receptor, it causes kidney function deficiency and has a death rate of 5-10%. (11) Cows, goats and other animals can naturally be a source of stx producing E. coli and other animals such as crabs also play a role in its transfer. (12) Transfer between humans can also take place. (13) Since shiga toxins cause many diseases, especially in children and immunocompromised elderly people, a rapid and sensitive diagnostic method with prognostic information would be rather useful. So far, many different detection methods such as cell culture, serological and molecular methods such as RPLA, real-time, PCR, hybridization have been utilized to detect shiga toxins or their respective genes. (14) Yet, all these methods have their own shortcomings as they are time-consuming, quite costly and have limitations in handling many samples simultaneously. At present, although molecular methods such as PCR and hybridization, despite being less time-consuming, less costly, and more sensitive, they are not suitable as they rely on agarose electrophoresis with carcinogen ethidium bromide, a major health threat for lab personnel, and does not allow analysis of many samples at a time in case of epidemic breakouts. (15) Nevertheless, real-time PCR despite 100% specificity and high sensitivity has not gained much attention because of high costs of fluorescent material and shortage of expert personnel. (16) To overcome shortcomings of the aforementioned methods, PCR-ELISA is an appropriate alternative approach for detecting stx genes, which is safe and non-radioactive. PCR-ELISA is more convenient for rapid and reliable detection and quantification of pathogen-specific gene sequences. (17,18) Besides having been used in medical and food industries, PCR-ELISA has also been used in the veterinary industry. (19)

In this study, specific primers and probes for stx genes, amplification and labeling of products DIG-dUTP, hybridization of streptavidin with biotinylated probes and detection with antibody against conjugated digoxigenin and peroxidase in microtiter plates were designed. We identified specific sequences of stx genes in a large number of samples using small amounts simultaneously with considerable sensitivity and short turnaround time.

Materials and methods

Bacterial strains

Shigella dysenteriae and E. coli O157:H7 strains were provided from Shahed University, Tehran, Iran and Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi, Klebsiella pneumonia and Vibrio cholera strains were provided by Baqiyatallah University of Medical Sciences, Tehran, Iran. The strains were verified by biochemical and immunologic methods.

Extraction of bacterial genomic DNA

To extract genomic DNA from Shigella dysenteriae and E. coli O157:H7 bacteria were incubated in liquid LB medium for 18 h in 37[degrees]C. Bacterial culture was centrifuged in 3000 rpm for 5 min. The pellet was resuspended in 300 [micro]L TE buffer followed by lysis solution containing 10 [micro]L lysozyme (10 mg/mL), 200 [micro]L SDS 20%, 3 [micro]L proteinase K and incubated in 37[degrees]C for 60 min. DNA was purified by extraction with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) in the presence of 5 M sodium perchlorate. A 1/10 volume of 3 M sodium acetate and 2 volumes of absolute ethanol were added and incubated in -20[degrees]C for 13 h. The genome was pelleted by centrifugation, washed with 70% ethanol and dried. Finally, DNA samples were dissolved in 100 [micro]L TE buffer and, to eliminate RNA, 3 [micro]L RNase A was added and the tubes were incubated in 37[degrees]C for 30 min.

The concentration and purity of the DNA samples were determined spectrophotometrically at A260 and A280 by NanoDrop 2000, Thermo Scientific (USA).

Primer and probe design

To design primers and the nucleic-acid sequencing probes, central parts of shiga toxin genes were used as template. Features in the designed primers such as GC content; Tm, [DELTA]G, etc. were checked by DNASIS and Oligo7 softwares. The primer and probe sequences are illustrated in Table 1. The oligonucleotides were supplied by CinnaClone (IRAN).

Isolation and amplification of stx1 and stx2 genes by PCR

PCR reagents in a final volume of 25 [micro]L included: 1 [micro]L template DNA, 0.5 [micro]L Taq DNA polymerase (5 U/[micro]L), 1 [micro]L of each primer (10 pmol/[micro]L), 1 [micro]L dNTP mixture, 2.5 [micro]L 10 x PCR buffer, 1.5 [micro]L Mg[Cl.sub.2] (50 mM) and 16.5 [micro]L sterile DDW. Thermal cycling of amplification mixture was performed in 30 cycles. (20)

The PCR program was carried out at 94[degrees]C for 3 min followed denaturing for 45 s at 94[degrees]C, annealing for 45 s at 59[degrees]C and an extension for 1 min at 72[degrees]C. The final extension was at 72[degrees]C for 5 min. PCR products were electrophoresed in 1% agarose followed by staining with ethidium bromide (0.5 [micro]g/mL) then visualized under ultraviolet light, and the results were recorded by photography. PCR products were verified by sequencing. For labeling of PCR products, the reaction of PCR was performed by dNTP mixture containing digoxigenin labeling mix (Digoxigenin dNTPs, Roche, Germany) with the same condition.

Detection of PCR products by ELISA

One microgram avidin were coated on ELISA plates, one well was placed as a negative control. Then, plates were washed with PBS (pH 7.2) containing 0.05% Tween 20 (PBST) and the blocked by 3% BSA buffer. In addition, 10 [micro]L of each labeled product of stx1 and stx2 genes were added to 90 1x SSC buffer in 1.5 mL tubes and incubated in boiling water for 10 min and then 5 min on ice. In the next step, 10 [micro]L of stx1 and stx2 probes were added to each tube and after 2h in 60[degrees]C, 100 [micro]L from this hybridization solution were added to each well and after 1 h in 37[degrees]C, it was washed with 20% BPST buffer 3 times. A 1/1000 solution of anti-digoxigenin antibody conjugated with peroxides in PBST buffer was prepared and 100 [micro]L of this solution was added to each well (including controls) and after 1 h in 37[degrees]C the plates were washed and dried as described earlier. 100 [micro]L of substrate solution (2 mg OPD, 100 [micro]L detection buffer, 5 [micro]L 30% hydrogen peroxide) was added to wells. 100 [micro]L of 1M [H.sub.2]S[O.sub.4] was added to stop the reaction. (21) The optical density was measured at 490 nm using an ELISA reader (Dynex Technologies, Guornesey, Channel Islands and Great Britain).

Evaluation PCR specificity and sensitivity

To determine the specificity, PCR was carried out with genomic DNA extracted from Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi C, Klebsiella pneumonia and Vibrio cholera. Products were analyzed on 1% agarose gel. To determine the minimum genomic DNA concentration that could be detected by the method, serially diluted genomic DNA in TE buffer (pH = 8) was used as PCR template and the product was analyzed on 1% agarose gel.

Sensitivity evaluation of PCR-ELISA technique using labeled PCR products of stx1 and stx2

To determine the detection limit for stx gene, genomic DNA was extracted and tenfold serial dilutions containing 108 ng/[micro]L to 0.108 pg/[micro]L and 156 ng/[micro]L to 0.156 pg/[micro]L of E. coli O157:H7 and Shigella dysenteriae genomic DNA, respectively, were prepared and all the steps were carried out as described previously. (22)

PCR-ELISA specificity evaluation using bacterial strains

To evaluate specificity of PCR-ELISA, E. coli O157:H7, Shigella dysenteriae, Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi C and Klebsiella pneumonia strains were grown in LB medium. Genomic DNAs were extracted and after evaluating their concentration by NanoDrop, [10.sup.-2] fold dilution was prepared as templates. The PCR was carried out according to mentioned protocols and the products were analyzed by agarose gel electrophoresis and ELISA. (22)

Clinical samples analysis

In this study 63 positive samples of Shigella dysenteriae and E. coli O157:H7 obtained from stool and urine cultures were analyzed. Samples were gathered from Mazandaran hospitals in a 3-month period between January and March of 2013. Age groups included children between 8 months to 10 years old, adults between 20 and 30 and between 50 and 90 years old (Table 2). Samples were transferred to the lab, cultured, and after growth were identified in differential and specific media and verified by specific antiserums. Following DNA extraction by boiling method, PCR-ELISA was carried out. Data analysis was performed on SPSS.

Results

PCR

DNA from extracted genome of bacteria cultured in LB medium was available in large quantities and was of good quality. The purity of the DNA samples was confirmed by absorbance (A260/A280) ratio, which was 1.8-2.0. PCR was performed for each strain with specific primers. Each PCR product was obtained as clear band at 275 and 490 bp generated by stx2 and stx1 genes respectively (Fig. 1b). The sizes of PCR products were the same as predicted.

Specificity of PCR

After validation of PCR products, specificity of the reaction was examined using genomes of Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi C, Klebsiella pneumonia and Vibrio cholera. As shown in Fig. 2, no cross-reaction was found between the individual primers and non-target pathogens in the PCR.

Sensitivity of PCR

After preparing a serial dilution from E. coli O157:H7 and Shigella dysenteriae at a primary concentration of 108ng/[micro]L and 156ng/[micro]L, the PCR reactions were performed on these dilutions and the results are displayed in Fig. 3. Regarding concentrations of the primary sample (108 ng/[micro]L and 156 ng/[micro]L), sensitivity of the reaction was calculated as 1.08 pg/[micro]L and 1.56 pg/[micro]L, respectively.

Specific PCR with dNTP DIG labeling mix

A PCR reaction was performed with digoxigenin labeling mix and the results were analyzed on 1% agarose gel (Fig. 4).

PCR-ELISA specificity and sensitivity assay

The specificity of the PCR-ELISA was analyzed using genomes of Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi C, Klebsiella pneumonia and Vibrio cholera.

To determine the minimum detectable concentration of genomic DNA of Shigella dysenteriae and E. coli O157:H7, serial dilutions were subjected to the PCR-ELISA technique. The results (Fig. 5) demonstrate the possibility of detecting 1.08pg/[micro]L and 1.56pg/[micro]L E. coli O157:H7 and Shigella dysenteriae, respectively.

Clinical results

A total of 63 clinical samples were collected and screened for the presence of E. coli O157:H7 and Shigella dysenteriae strains.

Seventeen (26.98%) samples were detected as stx positive. Age distribution of the patients ranged from <1 to 90 years. E. coli O157:H7 and Shigella dysenteriae infected patients had an average age of 23.17 years, and 47.05% were less than 10 years old (Table 2). The most common symptoms were bloody stools (88.23%) and abdominal pain (47.05%). Sex distribution of E. coli O157:H7 and Shigella dysenteriae infected patients were 7 females (41.18%), and 10 males (58.82%). Bacteriological culture results were compared to those obtained by PCR-ELISA. Results obtained from PCR-ELISA assay (Fig. 6) and from selective culture were compared. There was a significant association between PCR-ELISA and culture results for detecting and screening E. coli O157:H7 and Shigella dysenteriae. (p<0.001).

Discussion

Shiga toxin producing bacteria infection is a major health concern even in developed countries all over the world. (9,23,24) With increasing reports of E. coli O157:H7 and Shigella dysenteriae infections, great attention has been given to the development of methods for detecting these pathogens and approaches for prevention and treatment of these infections. This study was intended to reach part of these aims.

In recent years, ELISA test has been designed to detect shiga toxins directly in stool samples. The test is rapid and has a good potential for shiga toxin detection since it can detect the presence of shiga toxin-producing E. coli (STEC) or other shiga toxin-producing bacteria. Since shiga toxin type differentiation requires high cost monoclonal and polyclonal antibodies it is not widely used. Hybridization method is an effective, highly sensitive and specific molecular method for precise detection of shiga toxins, and uses non-radioactive substances such as digoxigenin and biotin. However, since it is not suitable for using in large number of clinical samples, this method is not used in many clinical labs. (25)

In contrast to serological and microbiological tests, PCR provides a rapid and sensitive alternative. This technique, first developed by Karch and Meyer, includes a primer pair from a conserved region of stx1 and stx2 in homologous genes whose main defects were low Tm and ineffectiveness in different types of shiga toxins. (15) In that regard, to detect different types of shiga toxins it is necessary to design a multiplex PCR with at least two pairs of primers to detect shiga toxin gene. The first study on multiplex PCR detection shiga toxins was by Cebula et al. who designed specific primers and used a fragment as positive internal control. Nonetheless, primers were only able to detect stx2. (26) Subsequent studies were carried out by Paton et al., Pass et al., Philot et al., and Belanger et al. Their main disadvantage was that all fragments were low-size and were hard to dissolve in agarose gel. (14,27,28) The primers that we designed for this study, after comparison with available data from gene banks, using software and experiment on clinical samples, proved to lack the above mentioned disadvantages and to be able of amplify different shiga toxin genes. In addition, these amplified fragments were easily dissolved in agarose gel and both stx1 and stx2 genes could be simultaneously detected in clinical samples. One potential problem of PCR is the presence of inhibitors, which may cause false results of the test. In Gram negative bacteria different lipids, carbohydrates, and proteins present in cell wall can act as inhibitors and reduce the sensitivity of the reaction. (29) To overcome these limitations and to increase sensitivity, bacterial genome must be purified before carrying out the reaction. Frank et al. in 1998 used the boiling method to extract genomic DNA; however, in this method inhibitors could not be eliminated. (30) Wang et al. in 2002 used SDS, lysozyme, tris, glucose and EDTA for extraction which increased sensitivity to 100pmol/[micro]L. (31) In 2011, Marzony et al. removed inhibitors and extracted genomic DNA by using CTAB and 5M NaCl and reported a sensitivity of 2.1pg/[micro]L. (32) Comparing PCR-ELISA with Vero cell assays, Fach et al. (33) showed that results with PCR were obtained within 24 h whereas with Vero cell assays results were available only after five days. Furthermore, Beilei et al. developed PCR-ELISA methods to detect Escherichia coli O157:H7 and other Shiga toxin-producing E. coli (STEC) in food, where 105 CFU of STEC per gram of ground beef detected without any culture enrichment by PCR-ELISA. (34)

In this study, inhibitors were effectively eliminated by using TE buffer, lysozyme, 20% SDS, proteinase K, RNase A, 3 M Sodium Acetate and cold isopropanol. Consequently, sensitivity of the test improved to 1.08pg/[micro]L. PCR-ELISA was successfully carried out with genomic DNA extracted from clinical samples; from Shigella dysenteriae, a 490 bp fragment was amplified as mentioned earlier. For E. coli O157:H7 both 490 and 275 bp fragments were amplified demonstrating that it can produce both toxins. PCR-ELISA correctly confirmed the specific stx1 and stx 2 genes. Non-positive results for other strains indicate that the tests are highly specific. Moreover, we have compared the performance of PCR-ELISA with standard agarose gel electrophoresis. PCRELISA assay was more sensitive than the gel electrophoresis. Our data indicate that PCR-ELISA is highly specific, and has higher sensitivity than conventional gel electrophoresis. By offering shorter turnaround time and high sensitivity, PCR-ELISA has the potential to serve as a powerful detection tool in medicine and in food and agricultural industries.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgement

This work was supported by Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, and the part of this project was dissertation of Askary ahmadpour, submitted to Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran in partial fulfillment of the requirements for the MSc in microbiology.

REFERENCES

(1.) Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coii infections. Clin Microbiol Rev. 1998;11:450-79.

(2.) Karmali MA. Infection by Shiga toxin-producing Escherichia coli. Mol Biotechnol. 2004;26:117-22.

(3.) Karmali MA. Prospects for preventing serious systemic toxemic complications of shiga toxin-producing Escherichia coli infections using shiga toxin receptor analogues. J Infect Dis. 2004;189:355-9.

(4.) Lingwood CA. Shiga toxin receptor glycolipid binding. Methods Mol Med. 2002;73:165-86.

(5.) Endo YTsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. Eur J Biochem. 1988;171:45-50.

(6.) Foster GH, Tesh VL. Shiga toxin 1-induced activation of c-Jun NH2-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-[alpha]. J Leukoc Biol. 2002;71:107-14.

(7.) Huang A, Friesen J, Brunton J. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. J Bacteriol. 1987;169:4308-12.

(8.) Gobius KS, Higgs GM, Desmarchelier PM. Presence of activatable Shiga toxin genotype (stx2d) in Shiga toxigenic Escherichia coli from livestock sources. J Clin Microbiol. 2003;41:3777-83.

(9.) Sack D, Hoque S, Etheridge M, Huq A. Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides? Lancet. 1994;343:1413-5.

(10.) Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatrics. 1994;125:511-8.

(11.) Siegler RL. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome. JAMA. 2003;290:1379-81.

(12.) Urdahl A, Beutin L, Skjerve E, Zimmermann S, Wasteson Y. Animal host associated differences in Shiga toxin-producing Escherichia coli isolated from sheep and cattle on the same farm. J Appl Microbiol. 2003;95:92-101.

(13.) Kumar H, Karunasagar I, Karunasagar I, Teizou T, Shima K, Yamasaki S. Characterisation of Shiga toxin-producing Escherichia coli (STEC) isolated from seafood and beef. FEMS Microbiol Lett. 2004;233:173-8.

(14.) Philpott D, Ebel F. E. coli: shiga toxin methods and protocols. Springer; 2003.

(15.) Karch H, Meyer T. Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J Clin Microbiol. 1989;27:2751-7.

(16.) Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26-38.

(17.) Daly P, Collier T, Doyle S. PCR-ELISA detection of Escherichia coli in milk. Lett Appl Microbiol. 2002;34:222-6.

(18.) Perelle S, Dilasser F Malorny B, Grout J, Hoorfar J, Fach P. Comparison of PCR-ELISA and LightCycler real-time PCR assays for detecting Salmonella spp. in milk and meat samples. Mol Cell Probes. 2004;18:409-20.

(19.) Kobets T, Badalova J, Grekov I, Havelkova H, Svobodova M, Lipoldova M. Leishmania parasite detection and quantification using PCR-ELISA. Nat Protoc. 2010;5:1074-80.

(20.) Ahmadpour A, Amani J, Imani Fooladi AA, Sedighian H, Nazarian S. Detection of Shigella dysenteriae and E. coli O157:H7 toxins by multiplex PCR method in clinical samples. Iran J Med Microbiol. 2013;7:41-51.

(21.) Mousavi SL, Nazarian S, Amani J, Rahgerd Karimi A. Rapid screening of toxigenic vibrio cholerae O1 strains from south Iran by PCR-ELISA. Iran Biomed J. 2008;12:15-21.

(22.) Mousavi SL, Salimiyan J, Rahgerdi AK, Amani J, Nazarian S, Ardestani H. A rapid and specific PCR-ELISA for detecting Salmonella typhi. Iran J Clin Infect Dis. 2006;1:113-9.

(23.) Sandvig K. Shiga toxins. Toxicon. 2001;39:1629-35.

(24.) Kargar M, Daneshvar M, Homayoun M. Surveillance of virulence markers and antibiotic resistance of shiga toxin producing E. coli O157:H7 Strains from Meats Purchase in Shiraz. ISMJ. 2011;14:76-83.

(25.) Jackson MP. Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP. J Clin Microbiol. 1991;29:1910-4.

(26.) Cebula TA, Payne WL, Feng P.Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol. 1995;33:248-50.

(27.) Belanger SD, Boissinot M, Menard C, Picard FJ, Bergeron MG. Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler. J Clin Microbiol. 2002;40:1436-40.

(28.) Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930-6.

(29.) Tamminen M, Joutsjoki T, Sjoblom M, et al. Screening of lactic acid bacteria from fermented vegetables by carbohydrate profiling and PCR-ELISA. Lett Appl Microbiol. 2004;39:439-44.

(30.) Franck SM, Bosworth BT, Moon HW. Multiplex PCR for enterotoxigenic, attaching and effacing, and Shiga toxin-producing Escherichia coli strains from calves. J Clin Microbiol. 1998;36:1795-7.

(31.) Wang G, Clark CG, Rodgers FG. Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. J Clin Microbiol. 2002;40:3613-9.

(32.) Marzony ET, Kamali M, Saadati M, Keihan AH, Fooladi AAI, Sajjadi S. Single multiplex PCR assay to identify the shiga toxin. Afr J Microbiol Res. 2011;5:1794-800.

(33.) Fach P, Perelle S, Dilasser F Grout J. Comparison between a PCR-ELISA test and the vero cell assay for detecting Shiga toxin-producing Escherichia coli in dairy products and characterization of virulence traits of the isolated strains. J Appl Microbiol. 2001;90:809-18.

(34.) Ge B, Zhao S, Hall R, Meng J. A PCR-ELISA for detecting Shiga toxin-producing Escherichia coli. Microbes Infect. 2002;4:285-90.

Jafar Amani (a), Askary Ahmadpour (a), Abbas Ali Imani Fooladi (a), *, Shahram Nazarian (b)

(a) Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

(b) Imam Hossain University, Faculty of Science, Department of Biology, Tehran, Iran

ARTICLE INFO

Article history:

Received 14 October 2014

Accepted 21 February 2015

Available online 21 April 2015

* Corresponding author at: Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Vanak Sq. Molasadra St., P.O. Box 19395-5487, Tehran, Iran.

E-mail address: imanifouladi.a@gmail.com (A.A. Imani Fooladi).

http://dx.doi.org/10.1016/j.bjid.2015.02.008

Table 1--PCR primers and hybridization capture probe
for stxl and stx2 genes.

Oligonucleotide              Sequence              Nucleotide
                                                    position

Ah stx1F          TTGTTTGCAGTTGATGTCAGAGG           210-233
Ah stx1R          CAGGCAGGACACTACTCAACCTTC          676-700
Ah stx2F          TTGCTGTGGATATACGAGGGC             214-235
Ah stx2R          CGCCAGATATGATGAAACCAGTG           466-489
p Stx1            Biotin-TGTTGCAGGGATCAGTCGTACG     422-444
p Stx2            Biotin-CATATATCAGTGCCCGGTGTG      355-376

Oligonucleotide   Expect product
                    size (bp)

Ah stx1F               275
Ah stx1R
Ah stx2F               490
Ah stx2R
p Stx1                  --
p Stx2                  --

Table 2--Clinical characteristics of patients.

Patient ID   Age (years)   Sex   Type of specimen

2                30         F      Bloody stool
3                20         F      Bloody stool
8                 8         M      Bloody stool
10                6         M      Bloody stool
14               20         F      Bloody stool
15               56         M      Bloody stool
18               20         M      Bloody stool
20                6         F      Bloody stool
23                9         M      Watery stool
27                8         M      Bloody stool
32               57         M      Bloody stool
35                9         M      Bloody stool
43               25         F      Bloody stool
47               50         F      Bloody stool
53                7         M      Bloody stool
55               55         F      Watery stool
59                8         M      Bloody stool

Patient ID   Clinical               Stx genotype
             manifestations

             Diarrhea   Abdominal
                          pain

2               +           +       Stx1/Stx2
3               +           +       Stx1/Stx2
8               +           +       Stx1/Stx2
10              +           +       Stx2
14              +           -       Stx2
15              +           -       Stx2
18              +           -       Stx2
20              +           +       Stx2
23              +           -       Stx2
27              +           +       Stx1/Stx2
32              +           -       Stx2
35              +           -       Stx2
43              +           +       Stx2
47              +           -       Stx2
53              +           +       Stx2
55              +           -       Stx2
59              +           -       Stx2
COPYRIGHT 2015 Contexto
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original article
Author:Amani, Jafar; Ahmadpour, Askary; Fooladi, Abbas Ali Imani; Nazarian, Shahram
Publication:The Brazilian Journal of Infectious Diseases
Article Type:Report
Geographic Code:9JAPA
Date:May 1, 2015
Words:4229
Previous Article:Quality of antenatal care as a risk factor for early onset neonatal infections in Rio de Janeiro, Brazil.
Next Article:Prevalence of hepatitis B and C virus infections among military personnel.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters